Design of a liposome with the property to induce CD16 on cervical cancer cells with a purified spermidine-cholesterol
Source abstract
Abstract
Abstract The purpose of the study is to investigate the use of a purified cationic lipid for fabricate liposomes capable of inducing the appearance of CD16 receptors on the membranes of cervical carcinoma cells. The methods used in this study are chemical synthesis of purified spermidine-cholesterol, liposome fabrication, UPLC-MS analysis, cell culture, and flow cytometry. This study reveals the construction of a liposomal system with a highly purified spermidine-cholesterol with CD16 inducing capacity on cervical cancer cells. We were able to synthetize a highly purified spermidine-cholesterol to fabricate a liposomal system capable to induce CD16 on cervical cancer cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M et al (2023) Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Lett 34(2):10751810.1016/j.cclet.2022.05.032 ↗
2. Selmani A, Kovačević D, Bohinc K (2022) Nanoparticles: from synthesis to applications and beyond. Adv Coll Interface Sci 303:10264010.1016/j.cis.2022.102640 ↗
3. Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK (2022) A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials, and patents. BioNanoSci 12(1):274–29110.1007/s12668-022-00941-x ↗
4. Forestal RL, Lee HI, Pi S, Liu S (2022) Spatio-temporal clustering analysis and technological forecasting of nanotechnology using patent data. Technol Anal Strateg Manag 1–17. https://doi.org/10.1080/09537325.2022.206900610.1080/09537325.2022.2069006 ↗
5. Nsairat H, Khater D, Sayed U, Odeh F, Bawab AA, Alshaer W (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8(5):e09394. https://doi.org/10.1016/j.heliyon.2022.e0939410.1016/j.heliyon.2022.e09394 ↗
6. Ewert KK, Scodeller P, Simón-Gracia L, Steffes VM, Wonder EA, Teesalu T, Safinya CR (2021) Cationic liposomes as vectors for nucleic acid and hydrophobic drug therapeutics. Pharmaceutics 13(9):136510.3390/pharmaceutics13091365 ↗
7. Filipczak N, Pan J, Yalamarty SSK, Torchilin VP (2020) Recent advancements in liposome technology. Adv Drug Deliv Rev 156:4–2210.1016/j.addr.2020.06.022 ↗
8. Andrade S, Loureiro JA, Ramirez S, Catumbela CS, Soto C, Morales R, Pereira MC (2022) Multi-dose intravenous administration of neutral and cationic liposomes in mice: an extensive toxicity study. Pharmaceuticals 15(6):76110.3390/ph15060761 ↗
9. Inglut CT, Sorrin AJ, Kuruppu T, Vig S, Cicalo J, Ahmad H, Huang HC (2020) Immunological and toxicological considerations for the design of liposomes. Nanomaterials 10(2):19010.3390/nano10020190 ↗
10. Gao X, Huang L (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun. Univ Tenn, United States Am 179(1):280–28510.1016/0006-291X(91)91366-K ↗
11. Rangel-Corona, R., Corona-Ortega, T., del Río-Ortiz, I., Nieves-Ramírez, M. E., Morán-Bañuelos, H., González-Tenorio, O., ... & Weiss-Steider, B. (2011). Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice. Journal of Drug Targeting, 19(2), 79–85.10.3109/10611861003733920 ↗
12. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Chang AE (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci 90(23):11307–1131110.1073/pnas.90.23.11307 ↗
13. Moradpour D, Schauer JI, Zurawski VR Jr, Wands JR, Boutin RH (1996) Efficient gene transfer into mammalian cells with cholesteryl-spermidine. Biochem Biophys Res Commun 221(1):82–8810.1006/bbrc.1996.0549 ↗
14. Bischoff R, Cordier Y, Perraud F, Thioudellet C, Braun S, Pavirani A (1997) Transfection of myoblasts in primary culture with isomeric cationic cholesterol derivatives. Anal Biochem 254(1):69–8110.1006/abio.1997.2401 ↗
15. Maslov MA, Kabilova TO, Petukhov IA, Morozova NG, Serebrennikova GA, Vlassov VV, Zenkova MA (2012) Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA. J Control Release 160(2):182–193. https://doi.org/10.1016/j.jconrel.2011.11.02310.1016/j.jconrel.2011.11.023 ↗
16. Wang J, Ye X, Ni H, Zhang J, Ju S, Ding W (2019) Transfection efficiency evaluation and endocytosis exploration of different polymer condensed agents. DNA Cell Biol 38(10):1048–1055. https://doi.org/10.1089/dna.2018.446410.1089/dna.2018.4464 ↗
17. Pick H, Alves AC, Vogel H (2018) Single-vesicle assays using liposomes and cell-derived vesicles: from modeling complex membrane processes to synthetic biology and biomedical applications. Chem Rev 118(18):8598–8654. https://doi.org/10.1021/acs.chemrev.7b0077710.1021/acs.chemrev.7b00777 ↗
18. Corona-Ortega TM, Soto-Vázquez R, Rangel-Corona R, Maria Huante-García R, Aguilar-Santelises L, Garcia del Valle A, Weiss-Steider B (2016) A Novel Nanocarrier system for cancer treatment. Curr Nanomed 6(2):133–14510.2174/2468187306999160427114000 ↗
19. Weiss-Steider B, Corona-Ortega MT, Rangel-Corona R (2021) Nanoliposomas catiónicos que contienen fosfatidilinositol y su uso para la inducción de la proliferación y la modificación del tráfico vesicular celular (Patente No. MX 387038 B). Ciudad de México, México: Universidad Nacional Autónoma de México
20. Rangel-Corona R, Corona-Ortega MT, Weiss-Steider B, Ibáñez-Hernández MÁA, Baeza-Ramírez MI (2015) Composición liposómica de IL-2 y su uso en el tratamiento de cáncer cervicouterino (Patente No. MX 330174 B). Ciudad de México, México: Universidad Nacional Autónoma de México; Instituto Politécnico Nacional
21. Corona-Ortega T, Rangel-Corona R, Hernández-Jiménez M, Baeza I, Ibáñez M, Weiss-Steider B (2009) Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor. J Drug Target 17(7):496–50110.1080/10611860903012810 ↗
22. Dormont F, Rouquette M, Mahatsekake C et al (2019) Translation of nanomedicines from lab to industrial scale synthesis: the case of squalene-adenosine nanoparticles. J Control Release 307:302–314. https://doi.org/10.1016/j.jconrel.2019.06.04010.1016/j.jconrel.2019.06.040 ↗
23. Mohs RC, Greig NH (2017) Drug discovery and Development: Role of basic Biological research. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 3(4):651–657. https://doi.org/10.1016/j.trci.2017.10.00510.1016/j.trci.2017.10.005 ↗
24. Wang Y, Luo Y, Li C, Zhang X, Pi C, Yu L, Wang S, Zhong Z (2017) Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro. Drug Des Devel Ther 11:955–968. https://doi.org/10.2147/dddt.s12879510.2147/dddt.s128795 ↗
25. Corona-Ortega T, Valle-Mendiola A, Rangel-Corona R, del Valle AG, Aguilar-Santelises L, Weiss-Steider B (2019) Cell proliferation and CD16 expression induced by liposomes containing PI (4, 5) P^ sub 2^. FarmaJ 4(1):262–263
26. Han Q, Wang W, Jia X, Qian Y, Li Q, Wang Z, Zhang W, Yang S, Jia Y, Hu Z (2016) Switchable liposomes: targeting-peptide-functionalized and pH-triggered cytoplasmic delivery. ACS Appl Mater Interfaces 8(29):18658–18663. https://doi.org/10.1021/acsami.6b0567810.1021/acsami.6b05678 ↗
27. Paliwal SR, Paliwal R, Vyas SP (2015) A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery. Drug Deliv 22(3):231–242. https://doi.org/10.3109/10717544.2014.88246910.3109/10717544.2014.882469 ↗
28. Aronson MR, Medina SH, Mitchell MJ (2021) Peptide functionalized liposomes for receptor targeted cancer therapy. APL Bioeng 5(1):011501. https://doi.org/10.1063/5.002986010.1063/5.0029860 ↗
29. Kinsey C, Lu T, Deiss A, Vuolo K, Klein L, Rustandi RR, Loughney JW (2021) Determination of lipid content and stability in lipid nanoparticles using ultra high-performance liquid chromatography in combination with a Corona Charged Aerosol Detector. Electrophoresis 43(9–10):1091–1100. https://doi.org/10.1002/elps.20210024410.1002/elps.202100244 ↗